Brind.

FDA Issues Class I Recall Notice for Spectra Medical Devices' Sodium Chloride Ampules

1 report, 1 independent Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The Food and Drug Administration identified a recall regarding specific 10-milliliter ampules of 0.9% sodium chloride used to flush IV tubing and catheters. The ampules, which are manufactured by Huons Co., Ltd., are sold by Spectra Medical Devices. The FDA stated that the recall notice applies to the product because an inspection of the manufacturer's facility identified quality issues with the injection.

From medicaldaily.com

Why it matters

Some supportBrind's analysis of the reports

The FDA classified the recall as the most serious type, warning that continued use of the device may cause serious injury or death. This notice signals a high-risk issue affecting the product line and its market viability.

From medicaldaily.com

Who's involved

  • SPECTRASpectra Medical Devices is the company selling the recalled sodium chloride ampules.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • SPECTRASpeculative

    Spectra Medical Devices could face serious financial impacts related to product liability, sales returns, and operational halts due to the Class I recall.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped